Nooshin Masoudian
1,2 
, Maryam Kakovan
3* , Samaneh Ghorbani Shirkouhi
4 , Fatemeh Ehsani
2 , Sasan Andalib
5,6,7* 1 Neurology Ward, Department of Internal Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
2 Neuromuscular Rehabilitation Research Center, Semnan University of Medical Sciences, Semnan, Iran
3 School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
4 Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
5 Research Unit of Neurology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
6 Department of Neurology, Odense University Hospital, Odense, Denmark
7 Neuroscience Research Center, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
*Corresponding Author: Neuroscience Research Center, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran Email mkakovanr@yahoo.com, sasan.andalib@health.sdu.dk
Abstract
Following the coronavirus disease 2019 (COVID-19) vaccination, complications are expected. In this regard, coagulopathy after COVID-19 vaccination has been reported. Here, we report a rare case of ischemic stroke subsequent to receiving the Beijing Bio-Institute of Biological Products - Coronavirus (BBIBP-CorV) vaccine (Sinopharm). Ten days after receiving the first dose of the BBIBP-CorV vaccine, a 76-year-old woman showed right central hemifacial weakness, balance disorder, and right hemisensory involvement with normal muscle force. Although the magnetic resonance imaging assessment revealed an acute lacunar stroke in her left thalamus, laboratory findings were normal. Based on our report, ischemic stroke may be a post-complication of BBIBP- CorV vaccination. However, further studies are needed to confirm this finding.